RZLT Earnings Date: Nov 5, 2026 (Estimated) — Rezolute, Inc.
NASDAQ · Healthcare · Biotechnology
Updated
When is RZLT's next earnings date?
Rezolute, Inc. (RZLT) is expected to report Q1 2027 earnings on Thursday, November 5, 2026 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.18 on revenue of $1.1M.
How did RZLT do in its last earnings report?
In its most recent report on Sep 24, 2026 (Q4 2026), Rezolute, Inc. posted EPS of -$0.20 versus the -$0.15 estimate, a miss of 42.9%. Revenue was $0. The stock's 1-day post-earnings move was -1.0%.
How much does RZLT stock move after earnings?
RZLT beat EPS estimates in 3 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 4.4% (up or down) in the day after earnings.
About Rezolute, Inc.
Rezolute, Inc., a late-stage rare disease company, focused on improving outcomes for individuals with hypoglycemia caused by hyperinsulinism in the United States. Its lead clinical asset is ersodetug, an intravenously administered human monoclonal antibody that is in Phase 3 clinical trial for the treatment of congenital hyperinsulinism, an ultra-rare pediatric genetic disorder, as well as for the treatment of hypoglycemia; and clinical trials of ersodetug for tumor hyperinsulinism. The company was formerly known as AntriaBio, Inc. and changed its name to Rezolute, Inc. in December 2017. Rezolute, Inc. was founded in 2010 and is headquartered in Redwood City, California.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-24 | Q4 2026 | -0.15 | -0.20 | -42.86% | $0 | ❌ Miss | -1.02% | +3.30% | -2.16% |
| 2026-05-12 | Q3 2026 | -0.16 | -0.16 | +0.00% | $0 | ➖ Inline | +0.91% | -6.06% | +16.97% |
| 2026-02-12 | Q2 2026 | -0.17 | -0.22 | -29.41% | $0 | ❌ Miss | +5.79% | -9.37% | -31.41% |
| 2025-11-06 | Q1 2026 | -0.27 | -0.18 | +33.33% | $0 | ✅ Beat | +12.08% | +3.54% | +5.94% |
| 2025-09-17 | Q4 2025 | -0.23 | -0.26 | -13.04% | — | ❌ Miss | +6.36% | +14.27% | +15.05% |
| 2025-02-12 | Q2 2025 | -0.25 | -0.22 | +12.00% | $0 | ✅ Beat | -1.03% | -4.73% | -25.93% |
| 2024-11-07 | Q1 2025 | -0.33 | -0.22 | +33.33% | $0 | ✅ Beat | -2.45% | -2.10% | -12.24% |
| 2024-09-19 | Q4 2024 | -0.33 | -0.44 | -33.33% | $0 | ❌ Miss | +5.39% | +1.24% | +0.62% |
Showing last 8 quarters.